NCI-MATCH Arms N & P: Phase II study of PI3K beta inhibitor GSK2636771 in patients (pts) with cancers (ca) with PTEN mutation/deletion (mut/del) or PTEN protein loss

F. Janku; O. Jegede; S. L. Puhalla; P. Konstantinopoulos; F. Meric-Bernstam; E. P. Mitchell; J. A. Zwiebel; L. M. McShane; S. Li; L. V. Rubinstein; L. A. Doyle; D. Patton; B. A. Conley; P. J. O'Dwyer; L. N. Harris; C. Arteaga; P. M. Williams; S. R. Hamilton; A. P. Chen; K. T. Flaherty

doi:10.1093/annonc/mdy279.406

NCI-MATCH Arms N & P: Phase II study of PI3K beta inhibitor GSK2636771 in patients (pts) with cancers (ca) with PTEN mutation/deletion (mut/del) or PTEN protein loss

F. Janku, O. Jegede, S. L. Puhalla, P. Konstantinopoulos, F. Meric-Bernstam, E. P. Mitchell, J. A. Zwiebel, L. M. McShane, S. Li, L. V. Rubinstein, L. A. Doyle, D. Patton, B. A. Conley, P. J. O'Dwyer, L. N. Harris, C. Arteaga, P. M. Williams, S. R. Hamilton, A. P. Chen, K. T. Flaherty

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	viii137
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy279.406
State	Published - Oct 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdy279.406

Cite this

Janku, F., Jegede, O., Puhalla, S. L., Konstantinopoulos, P., Meric-Bernstam, F., Mitchell, E. P., Zwiebel, J. A., McShane, L. M., Li, S., Rubinstein, L. V., Doyle, L. A., Patton, D., Conley, B. A., O'Dwyer, P. J., Harris, L. N., Arteaga, C., Williams, P. M., Hamilton, S. R., Chen, A. P., & Flaherty, K. T. (2018). NCI-MATCH Arms N & P: Phase II study of PI3K beta inhibitor GSK2636771 in patients (pts) with cancers (ca) with PTEN mutation/deletion (mut/del) or PTEN protein loss. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii137. https://doi.org/10.1093/annonc/mdy279.406

NCI-MATCH Arms N & P: Phase II study of PI3K beta inhibitor GSK2636771 in patients (pts) with cancers (ca) with PTEN mutation/deletion (mut/del) or PTEN protein loss. / Janku, F.; Jegede, O.; Puhalla, S. L. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii137.

Research output: Contribution to journal › Article › peer-review

Janku, F, Jegede, O, Puhalla, SL, Konstantinopoulos, P, Meric-Bernstam, F, Mitchell, EP, Zwiebel, JA, McShane, LM, Li, S, Rubinstein, LV, Doyle, LA, Patton, D, Conley, BA, O'Dwyer, PJ, Harris, LN, Arteaga, C, Williams, PM, Hamilton, SR, Chen, AP & Flaherty, KT 2018, 'NCI-MATCH Arms N & P: Phase II study of PI3K beta inhibitor GSK2636771 in patients (pts) with cancers (ca) with PTEN mutation/deletion (mut/del) or PTEN protein loss', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii137. https://doi.org/10.1093/annonc/mdy279.406

Janku F, Jegede O, Puhalla SL, Konstantinopoulos P, Meric-Bernstam F, Mitchell EP et al. NCI-MATCH Arms N & P: Phase II study of PI3K beta inhibitor GSK2636771 in patients (pts) with cancers (ca) with PTEN mutation/deletion (mut/del) or PTEN protein loss. Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Oct 1;29:viii137. doi: 10.1093/annonc/mdy279.406

@article{353a16604be74ad3ad20545d62c2f08c,

title = "NCI-MATCH Arms N & P: Phase II study of PI3K beta inhibitor GSK2636771 in patients (pts) with cancers (ca) with PTEN mutation/deletion (mut/del) or PTEN protein loss",

author = "F. Janku and O. Jegede and Puhalla, {S. L.} and P. Konstantinopoulos and F. Meric-Bernstam and Mitchell, {E. P.} and Zwiebel, {J. A.} and McShane, {L. M.} and S. Li and Rubinstein, {L. V.} and Doyle, {L. A.} and D. Patton and Conley, {B. A.} and O'Dwyer, {P. J.} and Harris, {L. N.} and C. Arteaga and Williams, {P. M.} and Hamilton, {S. R.} and Chen, {A. P.} and Flaherty, {K. T.}",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy279.406",

language = "English (US)",

volume = "29",

pages = "viii137",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - NCI-MATCH Arms N & P

T2 - Phase II study of PI3K beta inhibitor GSK2636771 in patients (pts) with cancers (ca) with PTEN mutation/deletion (mut/del) or PTEN protein loss

AU - Janku, F.

AU - Jegede, O.

AU - Puhalla, S. L.

AU - Konstantinopoulos, P.

AU - Meric-Bernstam, F.

AU - Mitchell, E. P.

AU - Zwiebel, J. A.

AU - McShane, L. M.

AU - Li, S.

AU - Rubinstein, L. V.

AU - Doyle, L. A.

AU - Patton, D.

AU - Conley, B. A.

AU - O'Dwyer, P. J.

AU - Harris, L. N.

AU - Arteaga, C.

AU - Williams, P. M.

AU - Hamilton, S. R.

AU - Chen, A. P.

AU - Flaherty, K. T.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081531565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081531565&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy279.406

DO - 10.1093/annonc/mdy279.406

M3 - Article

C2 - 32136211

SN - 0923-7534

VL - 29

SP - viii137

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

NCI-MATCH Arms N & P: Phase II study of PI3K beta inhibitor GSK2636771 in patients (pts) with cancers (ca) with PTEN mutation/deletion (mut/del) or PTEN protein loss

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this